Transform Patient Care
Integrate clinical-grade Lifetime Genomics Risk Assessments into your practice and identify up to 2-4x more at-risk patients compared to the current standard of family history
Transform Patient Care
Integrate clinical-grade Lifetime Genomics Risk Assessments into your practice and identify more at-risk patients compared to the current standard of family history. Over 40% of our patients are identified as increased risk for at least one disease empowering physicians with more data for proactive care management.
Evidence-Based, Clinically-Actionable
Our polygenic risk assessments are supported by substantial, peer-reviewed research. Our clinical support and implementation teams help providers translate this data into clinical action.
Improve Quality of Care
Identify more at-risk patients than family history guideline standard
Attract New Patients
Differentiate your services with leading-edge genomic insights similar to precision health hospital systems
Minimal Effort Required
Add personalized prevention, screening, and intervention with little to no incremental effort
Clinical Support
Our service provides access to curated genomic education and training to assist your practice in providing a premium patient experience
Education and Training
Customized resources like our knowledge base can help your clinical team stay up to date on rapidly advancing genomic research
At-Home or In-Office Collection
Draw blood in-office or we can ship easy-to-collect salvia kits to your patient's preferred address for discrete, confidential collection
Why is Common Genomic Variant Analysis so Valuable?
Only a small percentage of patients can accurately provide their family history, and traditional monogenic mutations (e.g., BRCA1/2) are rare in the population. Polygenic Risk Assessments, derived from millions of common genomic variants, can dramatically expand the amount of at risk individuals you can identify in your practice, allowing you to provide a foundational, genomic-based approach to your clinic. We offer individualized relative risk scores to provide you with the risk stratification intelligence to make more informed clinical decisions.